B.H.R. (Bruce) Wolffenbuttel

* The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control

Eli Lilly

* Fertility and obesity

PhD supervisor

* PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

Amgen

* A Randomized Trial Comparing Combined Basal Insulin/Glargine and Exenatide Therapy (BET) with Combined Basal Insulin/Glargine and Bolus Insulin/ Humalog Lispro Therapy (BBT) in Subjects with Type 2 Diabetes, Being Treated by Glargine with Metformin Alone or with Combination of Metformin with Sulfonylurea

Eli Lilly, now Amylin/BMS

* The effects of obesity and weight reduction on inflammatory markers and site-specific adipocyte function in prediabetes

PhD supervisor

* Quality of life after treatment for pituitary adenoma and Cushing's disease

PhD supervisor

* Use of the RFFT cognitive function test in large-scale epidemiologic studies

PhD supervisor

* Growth hormone replacement therapy in childhood cancer survivors

Novo Nordisk

* Personalized risk assessment and therapeutical strategy to prevent and treat macrovascular disease in Type 2 diabetes

PhD supervisor, Diabetes Research Foundation

* Cognitive function in pituitary diseases

PhD supervisor

* Thyroid hormone disturbances in the LifeLines Cohort Study

PhD supervisor

* IEMO Thyroid trial in subjects 80+

PI for UMCG

* GWA analysis for skin autofluorescence (together with AD Paterson, Toronto Canada & DCCT investigators)

* Endocrine disruptors and their effect in the pathophysiology of obesity and type 2 diabetes

* Metabolic syndrome & healthy obesity

PhD supervisor

* GWA analysis for T3T4 ratio in thyroid physiology

* Type 2 diabetes and its treatment across Europe, analysis in the BioSHaRE-EU consortium

PhD supervisor

* Long-term Type 1 diabetes

PI